PetMed Express stock rises after extending shareholder rights plan

Published 26/11/2025, 22:22
© Reuters.

Investing.com -- PetMed Express Inc (NASDAQ:PETS) stock rose 3.4% in after-hours trading on Wednesday following the company’s announcement that it extended its shareholder rights plan by one year.

The pet medication retailer’s Board of Directors unanimously approved an amendment to the existing plan, pushing the expiration date from December 2, 2025, to December 2, 2026. All other terms and conditions of the rights plan remain unchanged.

The company stated that the Board adopted the rights plan to protect shareholder investments during a period when it believes the company’s shares "do not reflect the inherent value of the business or its long-term growth potential." The Board also noted concerns about "recent significant accumulations of Company common stock by certain shareholders."

According to the announcement, the plan is designed to enable shareholders to realize long-term value and ensure fair treatment in the event of any proposed takeover. The company emphasized that the plan doesn’t interfere with any sale, merger, or business combination approved by the Board, nor does it prevent the Board from considering offers that recognize PetMed’s full value.

The rights plan is intended to guard against tactics to gain control of the company without paying all shareholders an appropriate premium.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.